how long have glp 1 drugs been on the market Glucagon-like peptide-1 receptor: mechanisms and advances in therapy

GLP 1 drug access and 2026 health benefits: What consumers expect New survey data shows 59% of Americans support the Trump administration's plan to broaden access to GLP 1 drugs for weight loss at discounted Blue Cross Blue Shield of Massachusetts will stop covering popular GLP 1 weight loss drugs like Ozempic and Wegovy starting January 1, 2026. The decision comes as the costs for these medications have skyrocketed, GLP 1 agonists and changes in body mass and composition in adults with overweight or obesity with or without type 2 diabetes mellitus: a systematic review and meta analysis International Journal of Obesity GLP 1 weight loss drugs are back in the news Exploration of the potential association between GLP 1 receptor agonists and suicidal or self injurious behaviors: a pharmacovigilance study based on the FDA Adverse Event Reporting System database BMC Medicine Springer Nature Genuinely dont know what Im meant to do to stop my name being used to endorse shonky products. This clearly isnt endorsed by me. The Guardian wrote an article about this problem, the rise in